{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T02:12:53Z","timestamp":1774059173334,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Copenhagen University Hospital Rigshospitalet","doi-asserted-by":"publisher","award":["R239-A10.335"],"award-info":[{"award-number":["R239-A10.335"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jgo.2025.102816","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T21:30:21Z","timestamp":1764970221000},"page":"102816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dizziness and impaired postural balance in older patients receiving chemotherapy treatment: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"17","author":[{"given":"Katrine Storm","family":"Piper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Puts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Ryg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Suetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Elkj\u00e6r","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob Vasehus","family":"Schou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jgo.2025.102816_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"Suppl. 5","key":"10.1016\/j.jgo.2025.102816_bb0010","article-title":"NCCN task force report: management of neuropathy in cancer","volume":"7","author":"Stubblefield","year":"2009","journal-title":"J Natl Compr Cancer Netw"},{"issue":"12","key":"10.1016\/j.jgo.2025.102816_bb0015","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jgo.2025.102816_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fonc.2018.00363","article-title":"Vestibulotoxicity associated with platinum-based chemotherapy in survivors of cancer: a scoping review","volume":"8","author":"Prayuenyong","year":"2018","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2025.102816_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/VES-170619","article-title":"Bilateral vestibulopathy: diagnostic criteria consensus document of the classification Committee of the Barany Society","volume":"27","author":"Strupp","year":"2017","journal-title":"J Vestibular Res Equilibrium Orientation"},{"issue":"9","key":"10.1016\/j.jgo.2025.102816_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac205","article-title":"World guidelines for falls prevention and management for older adults: a global initiative","volume":"51","author":"Montero-Odasso","year":"2022","journal-title":"Age Ageing"},{"issue":"8","key":"10.1016\/j.jgo.2025.102816_bb0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.6004\/jnccn.2019.7290","article-title":"Balance deficits and functional disability in Cancer survivors exposed to neurotoxic Cancer treatments","volume":"17","author":"McCrary","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jgo.2013.10.002","article-title":"Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: a retrospective cohort study","volume":"5","author":"Ward","year":"2014","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2025.102816_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MAO.0000000000003079","article-title":"Imbalance associated with cisplatin chemotherapy in adult cancer survivors: a clinical study","volume":"42","author":"Prayuenyong","year":"2021","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.jgo.2025.102816_bb0055","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jcsm.12483","article-title":"Sarcopenia: a time for action","volume":"10","author":"Bauer","year":"2019","journal-title":"An SCWD Position Paper J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.jgo.2025.102816_bb0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clon.2020.03.011","article-title":"Falls and Cancer","volume":"32","author":"Morris","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/japplphysiol.00005.2018","article-title":"Vascular and autonomic changes in adult cancer patients receiving anticancer chemotherapy","volume":"125","author":"Frye","year":"2018","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0070","first-page":"33","article-title":"Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer","volume":"30","author":"Teng","year":"2022","journal-title":"Support Care Cancer"},{"issue":"22","key":"10.1016\/j.jgo.2025.102816_bb0075","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of Vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2025.102816_bb0080","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/0284186X.2018.1531299","article-title":"Age-dependent differences in first-line chemotherapy in patients with metastatic colorectal cancer: the DISCO study","volume":"57","author":"Lund","year":"2018","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2025.102816_bb0085","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s41999-023-00919-2","article-title":"How to incorporate chronic health conditions in oncologic decision-making and care for older patients with cancer? A survey among healthcare professionals","volume":"15","author":"Seghers","year":"2024","journal-title":"Eur Geriatric Med"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgo.2019.03.020","article-title":"Falls in older patients with cancer: nursing and allied health Group of International Society of geriatric oncology review paper","volume":"11","author":"Sattar","year":"2020","journal-title":"J Geriatr Oncol"},{"issue":"26","key":"10.1016\/j.jgo.2025.102816_bb0095","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and Management of Vulnerabilities in older patients receiving systemic Cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102816_bb0100","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41416-021-01367-0","article-title":"The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)","volume":"124","author":"Lund","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2025.102816_bb0105","author":"TJ"},{"issue":"3","key":"10.1016\/j.jgo.2025.102816_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgo.2025.102816_bb0115","author":"Hadfield"},{"key":"10.1016\/j.jgo.2025.102816_bb0120","author":"NationalCancerInstitute"},{"key":"10.1016\/j.jgo.2025.102816_bb0125","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jgo.2025.102816_bb0130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jgo.2025.102816_bb0135","author":"Deeks"},{"issue":"7","key":"10.1016\/j.jgo.2025.102816_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jgo.2025.102816_bb0145","series-title":"Cochrane","article-title":"Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis","author":"Page","year":"2024"},{"key":"10.1016\/j.jgo.2025.102816_bb0150","series-title":"Cochrane","article-title":"Chapter 14: Completing \u2018summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2024"},{"issue":"2","key":"10.1016\/j.jgo.2025.102816_bb0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bjh.14536","article-title":"Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy","volume":"177","author":"Berdeja","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jgo.2025.102816_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4046\/trd.2018.0019","article-title":"The clinical efficacy and safety of four-weekly docetaxel as first-line therapy in elderly lung Cancer patients with squamous cell carcinoma","volume":"82","author":"Choi","year":"2019","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"5","key":"10.1016\/j.jgo.2025.102816_bb0165","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.21873\/anticanres.11586","article-title":"EAGLES study: first-line bevacizumab in combination with chemotherapy in elderly patients with advanced, metastatic, non-squamous non-small cell lung Cancer","volume":"37","author":"De Marinis","year":"2017","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.jgo.2025.102816_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00280-017-3289-6","article-title":"Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer","volume":"79","author":"Jang","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"10.1016\/j.jgo.2025.102816_bb0175","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00277-016-2768-x","article-title":"R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma","volume":"95","author":"Laribi","year":"2016","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.jgo.2025.102816_bb0180","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1159\/000525101","article-title":"Sequential geriatric assessment in older patients with colorectal Cancer during chemotherapy: subgroup analysis of a prospective, multicenter study EpiReal 75","volume":"45","author":"Li","year":"2022","journal-title":"Oncol Res Treat"},{"issue":"4","key":"10.1016\/j.jgo.2025.102816_bb0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00280-023-04526-7","article-title":"A prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged\u226580 years after curative resection of colorectal cancer, the HiSCO-03 study","volume":"91","author":"Okuda","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.jgo.2025.102816_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clml.2018.11.003","article-title":"Multicenter phase 2 study of reduced-dose CHOP chemotherapy combined with rituximab for elderly patients with diffuse large B-cell lymphoma","volume":"19","author":"Park","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pan.2018.10.004","article-title":"Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: results of the PANOVA phase 2 study","volume":"19","author":"Rivera","year":"2019","journal-title":"Pancreatology"},{"issue":"29","key":"10.1016\/j.jgo.2025.102816_bb0200","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.19.00861","article-title":"Phase II California Cancer consortium trial of gemcitabine-Eribulin combination in cisplatin-ineligible patients with metastatic urothelial carcinoma: final report (NCI-9653)","volume":"37","author":"Sadeghi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2025.102816_bb0205","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/10428194.2016.1243680","article-title":"Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemia","volume":"58","author":"Seymour","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.jgo.2025.102816_bb0210","first-page":"195","article-title":"The course of neuropathic symptoms in relation to adjuvant chemotherapy among elderly patients with stage III colon cancer: a longitudinal study","volume":"16","author":"van Erning","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"46","key":"10.1016\/j.jgo.2025.102816_bb0215","doi-asserted-by":"crossref","first-page":"81394","DOI":"10.18632\/oncotarget.19037","article-title":"DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study","volume":"8","author":"Woo","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.jgo.2025.102816_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2024.102059","article-title":"Dizziness and impaired walking balance in aging patients during chemotherapy","volume":"15","author":"Piper","year":"2024","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2025.102816_bb0225","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"issue":"n\/a","key":"10.1016\/j.jgo.2025.102816_bb0230","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"n\/a","author":"McGuinness","year":"2020","journal-title":"Res Synth Methods"},{"issue":"4","key":"10.1016\/j.jgo.2025.102816_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35766","article-title":"Relationships between patient-reported and clinician-rated toxicities and daily functioning in older adults with advanced cancer undergoing systemic therapy","volume":"131","author":"Culakova","year":"2025","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jgo.2025.102816_bb0240","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMp0911494","article-title":"The missing voice of patients in drug-safety reporting","volume":"362","author":"Basch","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jgo.2025.102816_bb0245","first-page":"3669","article-title":"The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review","volume":"24","author":"Atkinson","year":"2016","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jgo.2018.08.006","article-title":"The assessment, management, and reporting of falls, and the impact of falls on cancer treatment in community-dwelling older patients receiving cancer treatment: results from a mixed-methods study","volume":"10","author":"Sattar","year":"2019","journal-title":"J Geriatr Oncol"},{"issue":"17","key":"10.1016\/j.jgo.2025.102816_bb0255","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1200\/JCO.2012.41.6727","article-title":"Under-representation of older adults in cancer registration trials: known problem, little progress","volume":"30","author":"Scher","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0260","first-page":"78","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jgo.2025.102816_bb0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11136-013-0470-1","article-title":"Cognitive interviewing of the US National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"23","author":"Hay","year":"2014","journal-title":"Qual Life Res"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825006320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825006320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:36:05Z","timestamp":1774056965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406825006320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1879406825006320"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102816","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dizziness and impaired postural balance in older patients receiving chemotherapy treatment: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102816"}}